Lead Product(s) : Tiprelestat
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : Duke University | SRI International | National Heart, Lung, and Blood Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Subcutaneous Elafin in Healthy Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 14, 2018
Lead Product(s) : Tiprelestat
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : Duke University | SRI International | National Heart, Lung, and Blood Institute
Deal Size : Inapplicable
Deal Type : Inapplicable